ClinicalTrialsFinder

Autosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 2 (Disorder) Clinical Trials in London

1 recruitingLondon, United Kingdom

Showing 1–1 of 1 trials

Recruiting
Phase 1

A Trial Evaluating the Effect of NIO752 on Tau Synthesis Measured by a Process Known as SILK

Alzheimer DiseaseAutosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 1 (Disorder)Autosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 2 (Disorder)+1 more
University College, London10 enrolled2 locationsNCT06372821